Balloon Pulmonary Angioplasty in Technically Operable and Technically Inoperable Chronic Thromboembolic Pulmonary Hypertension.
balloon pulmonary angioplasty
chronic thromboembolic pulmonary hypertension
distal-type CTEPH
proximal-type CTEPH
pulmonary endarterectomy
Journal
Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588
Informations de publication
Date de publication:
03 Mar 2021
03 Mar 2021
Historique:
received:
10
01
2021
revised:
04
02
2021
accepted:
24
02
2021
entrez:
3
4
2021
pubmed:
4
4
2021
medline:
4
4
2021
Statut:
epublish
Résumé
In this study, we aimed to assess the efficacy and safety of balloon pulmonary angioplasty (BPA) in patients with technically inoperable distal-type chronic thromboembolic pulmonary hypertension (d-CTEPH) and technically operable proximal-type disease (p-CTEPH) by analyzing the results of BPA treatment in two collaborating CTEPH referral centers. We assessed hemodynamic results, functional efficacy, complication and survival rate after BPA treatment in 70 CTEPH patients (median age 64 years; (interquartile range (IQR): 52-73 years)), of whom 16 (median age 73 years; (QR 62-82 years)) were in the p-CTEPH subgroup. Altogether, 377 BPA procedures were performed, resulting in significant ( BPA may be beneficial in patients with p-CTEPH who cannot undergo pulmonary endarterectomy (PEA). Larger long-term studies are needed to better define the efficacy, safety, and optimal BPA procedural standards in this population.
Sections du résumé
BACKGROUND
BACKGROUND
In this study, we aimed to assess the efficacy and safety of balloon pulmonary angioplasty (BPA) in patients with technically inoperable distal-type chronic thromboembolic pulmonary hypertension (d-CTEPH) and technically operable proximal-type disease (p-CTEPH) by analyzing the results of BPA treatment in two collaborating CTEPH referral centers.
METHODS AND RESULTS
RESULTS
We assessed hemodynamic results, functional efficacy, complication and survival rate after BPA treatment in 70 CTEPH patients (median age 64 years; (interquartile range (IQR): 52-73 years)), of whom 16 (median age 73 years; (QR 62-82 years)) were in the p-CTEPH subgroup. Altogether, 377 BPA procedures were performed, resulting in significant (
CONCLUSION
CONCLUSIONS
BPA may be beneficial in patients with p-CTEPH who cannot undergo pulmonary endarterectomy (PEA). Larger long-term studies are needed to better define the efficacy, safety, and optimal BPA procedural standards in this population.
Identifiants
pubmed: 33802475
pii: jcm10051038
doi: 10.3390/jcm10051038
pmc: PMC7959461
pii:
doi:
Types de publication
Journal Article
Langues
eng
Subventions
Organisme : The Medical Centre of Postgraduate Education in Warsaw, Poland
ID : 501-1-54-01-19
Références
JACC Cardiovasc Interv. 2013 Jul;6(7):725-36
pubmed: 23769649
Ann Thorac Surg. 2003 Nov;76(5):1457-62; discussion 1462-4
pubmed: 14602267
Circ Cardiovasc Qual Outcomes. 2017 Nov;10(11):
pubmed: 29101270
JACC Cardiovasc Interv. 2013 Nov;6(11):1212-3
pubmed: 24262622
Cardiorenal Med. 2020;10(1):22-31
pubmed: 31527376
Circ Cardiovasc Interv. 2012 Dec;5(6):748-55
pubmed: 23192917
Kardiol Pol. 2015;73(12):1127-206
pubmed: 26727670
J Thorac Cardiovasc Surg. 2011 Mar;141(3):702-10
pubmed: 21335128
Eur Respir J. 2015 Oct;46(4):903-75
pubmed: 26318161
Ann Thorac Surg. 2006 Oct;82(4):1338-43; discussion 1343
pubmed: 16996930
Ann Am Thorac Soc. 2016 Jul;13 Suppl 3:S240-7
pubmed: 27571005
Ann Thorac Surg. 2012 Jul;94(1):97-103; discussion 103
pubmed: 22626752
EuroIntervention. 2018 Apr 20;13(17):2060-2068
pubmed: 28804055
Eur Respir Rev. 2017 Mar 15;26(143):
pubmed: 28298388
J Heart Lung Transplant. 2019 Aug;38(8):833-842
pubmed: 31103383
J Heart Lung Transplant. 2018 Sep;37(9):1102-1110
pubmed: 30037729
EuroIntervention. 2018 Feb 20;13(14):1728-1729
pubmed: 28691912
Circulation. 2016 Mar 1;133(9):859-71
pubmed: 26826181
Eur Respir J. 2009 Feb;33(2):332-8
pubmed: 18829679
Circulation. 2016 Dec 13;134(24):2030-2032
pubmed: 27956405
Postepy Kardiol Interwencyjnej. 2015;11(1):1-4
pubmed: 25848362
Eur Respir J. 2019 May 18;53(5):
pubmed: 31023842
Kardiol Pol. 2017;75(7):645-654
pubmed: 28553870
Clin Appl Thromb Hemost. 2016 Jan;22(1):92-9
pubmed: 24875780
Int J Cardiol. 2019 Mar 1;278:232-237
pubmed: 30409735
Ther Adv Respir Dis. 2019 Jan-Dec;13:1753466619891529
pubmed: 31878837
Circ Cardiovasc Interv. 2012 Dec;5(6):756-62
pubmed: 23132237
J Cardiol. 2020 Feb;75(2):182-188
pubmed: 31427133
Kardiol Pol. 2015;73(1):63-8
pubmed: 25625343
Circulation. 2007 Apr 24;115(16):2153-8
pubmed: 17420352
Ann Thorac Cardiovasc Surg. 2008 Oct;14(5):274-82
pubmed: 18989242
Chest. 2001 Mar;119(3):818-23
pubmed: 11243963
Am J Respir Crit Care Med. 2008 May 15;177(10):1122-7
pubmed: 18292468
Circulation. 2011 Nov 1;124(18):1973-81
pubmed: 21969018
Circulation. 2001 Jan 2;103(1):10-3
pubmed: 11136677
Eur Respir J. 2019 May 23;53(5):
pubmed: 31123025
Postepy Kardiol Interwencyjnej. 2017;13(2):180-181
pubmed: 28798794
Eur Respir J. 2017 Jun 8;49(6):
pubmed: 28596435